Cav3.1 (α1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells

Chun Zhou, Hairu Chen, Fengmin Lu, Hassan Sellak, Jonathan A. Daigle, Mikhail F. Alexeyev, Yaguang Xi, Jingfang Ju, Jan A. Van Mourik, Songwei Wu

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The T-type Ca2+ channel Cav3.1 subunit is present in pulmonary microvascular endothelial cells (PMVECs), but not in pulmonary artery endothelial cells (PAECs). The present study sought to assess the role of Cav3.1 in thrombin-induced Weibel-Palade body exocytosis and consequent von Willebrand factor (VWF) release. In PMVECs and PAECs transduced with a green fluorescent protein (GFP)-tagged VWF chimera, we examined the real-time dynamics and secretory process of VWF-GFP-containing vesicles in response to thrombin and the cAMP-elevating agent isoproterenol. Whereas thrombin stimulated a progressive decrease in the number of VWF-GFP-containing vesicles in both cell types, isoproterenol only decreased the number of VWF-GFP-containing vesicles in PAECs. In PMVECs, thrombin-induced decrease in the number of VWF-GFP-containing vesicles was nearly abolished by the T-type Ca2+ channel blocker mibefradil as well as by Cav3.1 gene silencing with small hairpin RNA. Expression of recombinant Cav3.1 subunit in PAECs resulted in pronounced increase in thrombin-stimulated Ca 2+ entry, which is sensitive to mibefradil. Together, these data indicate that VWF secretion from lung endothelial cells is regulated by two distinct pathways involving Ca2+ or cAMP, and support the hypothesis that activation of Cav3.1 T-type Ca2+ channels in PMVECs provides a unique cytosolic Ca2+ source important for G q-linked agonist-induced VWF release.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume292
Issue number4
DOIs
StatePublished - Apr 1 2007

Fingerprint

von Willebrand Factor
Endothelial Cells
Lung
Green Fluorescent Proteins
Thrombin
Pulmonary Artery
Mibefradil
Isoproterenol
Weibel-Palade Bodies
Secretory Pathway
Exocytosis
Gene Silencing
Small Interfering RNA

Keywords

  • Endothelial cells
  • Thrombin

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Cav3.1 (α1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells. / Zhou, Chun; Chen, Hairu; Lu, Fengmin; Sellak, Hassan; Daigle, Jonathan A.; Alexeyev, Mikhail F.; Xi, Yaguang; Ju, Jingfang; Van Mourik, Jan A.; Wu, Songwei.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 292, No. 4, 01.04.2007.

Research output: Contribution to journalArticle

Zhou, Chun ; Chen, Hairu ; Lu, Fengmin ; Sellak, Hassan ; Daigle, Jonathan A. ; Alexeyev, Mikhail F. ; Xi, Yaguang ; Ju, Jingfang ; Van Mourik, Jan A. ; Wu, Songwei. / Cav3.1 (α1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2007 ; Vol. 292, No. 4.
@article{3d8718a9f95d4cd8aceac3cdbb449d56,
title = "Cav3.1 (α1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells",
abstract = "The T-type Ca2+ channel Cav3.1 subunit is present in pulmonary microvascular endothelial cells (PMVECs), but not in pulmonary artery endothelial cells (PAECs). The present study sought to assess the role of Cav3.1 in thrombin-induced Weibel-Palade body exocytosis and consequent von Willebrand factor (VWF) release. In PMVECs and PAECs transduced with a green fluorescent protein (GFP)-tagged VWF chimera, we examined the real-time dynamics and secretory process of VWF-GFP-containing vesicles in response to thrombin and the cAMP-elevating agent isoproterenol. Whereas thrombin stimulated a progressive decrease in the number of VWF-GFP-containing vesicles in both cell types, isoproterenol only decreased the number of VWF-GFP-containing vesicles in PAECs. In PMVECs, thrombin-induced decrease in the number of VWF-GFP-containing vesicles was nearly abolished by the T-type Ca2+ channel blocker mibefradil as well as by Cav3.1 gene silencing with small hairpin RNA. Expression of recombinant Cav3.1 subunit in PAECs resulted in pronounced increase in thrombin-stimulated Ca 2+ entry, which is sensitive to mibefradil. Together, these data indicate that VWF secretion from lung endothelial cells is regulated by two distinct pathways involving Ca2+ or cAMP, and support the hypothesis that activation of Cav3.1 T-type Ca2+ channels in PMVECs provides a unique cytosolic Ca2+ source important for G q-linked agonist-induced VWF release.",
keywords = "Endothelial cells, Thrombin",
author = "Chun Zhou and Hairu Chen and Fengmin Lu and Hassan Sellak and Daigle, {Jonathan A.} and Alexeyev, {Mikhail F.} and Yaguang Xi and Jingfang Ju and {Van Mourik}, {Jan A.} and Songwei Wu",
year = "2007",
month = "4",
day = "1",
doi = "10.1152/ajplung.00377.2006",
language = "English (US)",
volume = "292",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - Cav3.1 (α1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells

AU - Zhou, Chun

AU - Chen, Hairu

AU - Lu, Fengmin

AU - Sellak, Hassan

AU - Daigle, Jonathan A.

AU - Alexeyev, Mikhail F.

AU - Xi, Yaguang

AU - Ju, Jingfang

AU - Van Mourik, Jan A.

AU - Wu, Songwei

PY - 2007/4/1

Y1 - 2007/4/1

N2 - The T-type Ca2+ channel Cav3.1 subunit is present in pulmonary microvascular endothelial cells (PMVECs), but not in pulmonary artery endothelial cells (PAECs). The present study sought to assess the role of Cav3.1 in thrombin-induced Weibel-Palade body exocytosis and consequent von Willebrand factor (VWF) release. In PMVECs and PAECs transduced with a green fluorescent protein (GFP)-tagged VWF chimera, we examined the real-time dynamics and secretory process of VWF-GFP-containing vesicles in response to thrombin and the cAMP-elevating agent isoproterenol. Whereas thrombin stimulated a progressive decrease in the number of VWF-GFP-containing vesicles in both cell types, isoproterenol only decreased the number of VWF-GFP-containing vesicles in PAECs. In PMVECs, thrombin-induced decrease in the number of VWF-GFP-containing vesicles was nearly abolished by the T-type Ca2+ channel blocker mibefradil as well as by Cav3.1 gene silencing with small hairpin RNA. Expression of recombinant Cav3.1 subunit in PAECs resulted in pronounced increase in thrombin-stimulated Ca 2+ entry, which is sensitive to mibefradil. Together, these data indicate that VWF secretion from lung endothelial cells is regulated by two distinct pathways involving Ca2+ or cAMP, and support the hypothesis that activation of Cav3.1 T-type Ca2+ channels in PMVECs provides a unique cytosolic Ca2+ source important for G q-linked agonist-induced VWF release.

AB - The T-type Ca2+ channel Cav3.1 subunit is present in pulmonary microvascular endothelial cells (PMVECs), but not in pulmonary artery endothelial cells (PAECs). The present study sought to assess the role of Cav3.1 in thrombin-induced Weibel-Palade body exocytosis and consequent von Willebrand factor (VWF) release. In PMVECs and PAECs transduced with a green fluorescent protein (GFP)-tagged VWF chimera, we examined the real-time dynamics and secretory process of VWF-GFP-containing vesicles in response to thrombin and the cAMP-elevating agent isoproterenol. Whereas thrombin stimulated a progressive decrease in the number of VWF-GFP-containing vesicles in both cell types, isoproterenol only decreased the number of VWF-GFP-containing vesicles in PAECs. In PMVECs, thrombin-induced decrease in the number of VWF-GFP-containing vesicles was nearly abolished by the T-type Ca2+ channel blocker mibefradil as well as by Cav3.1 gene silencing with small hairpin RNA. Expression of recombinant Cav3.1 subunit in PAECs resulted in pronounced increase in thrombin-stimulated Ca 2+ entry, which is sensitive to mibefradil. Together, these data indicate that VWF secretion from lung endothelial cells is regulated by two distinct pathways involving Ca2+ or cAMP, and support the hypothesis that activation of Cav3.1 T-type Ca2+ channels in PMVECs provides a unique cytosolic Ca2+ source important for G q-linked agonist-induced VWF release.

KW - Endothelial cells

KW - Thrombin

UR - http://www.scopus.com/inward/record.url?scp=34247180063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247180063&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00377.2006

DO - 10.1152/ajplung.00377.2006

M3 - Article

VL - 292

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 4

ER -